Dermatologic Therapy

3.4k papers and 44.1k indexed citations i.

About

The 3.4k papers published in Dermatologic Therapy in the last decades have received a total of 44.1k indexed citations. Papers published in Dermatologic Therapy usually cover Dermatology (1.9k papers), Epidemiology (821 papers) and Immunology (580 papers) specifically the topics of Dermatology and Skin Diseases (581 papers), Dermatologic Treatments and Research (484 papers) and Autoimmune Bullous Skin Diseases (424 papers). The most active scholars publishing in Dermatologic Therapy are Clive R. Harding, Torello Lotti, Anthony V. Rawlings, Zoe Diana Draelos, Uwe Wollina, Elise A. Olsen, Valerie A. Randall, John Koo, Audrey Kelly and Robert A. Norman.

In The Last Decade

Fields of papers published in Dermatologic Therapy

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Dermatologic Therapy. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Dermatologic Therapy

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Dermatologic Therapy. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Dermatologic Therapy with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025